about
The aftermath of the Merck's HIV vaccine trialGenetically modified hematopoietic stem cell transplantation for HIV-1-infected patients: can we achieve a cure?Epigenetic regulation of HIV-1 latency by cytosine methylationRetroviral DNA Integration"Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence.Cell-type-specific proteome and interactome: using HIV-1 Tat as a test case.Epigenetic analysis of HIV-1 proviral genomes from infected individuals: predominance of unmethylated CpG's.Combinatorial latency reactivation for HIV-1 subtypes and variantsCell line-dependent variability in HIV activation employing DNMT inhibitorsDendritic cell-induced activation of latent HIV-1 provirus in actively proliferating primary T lymphocytesVisualization of positive transcription elongation factor b (P-TEFb) activation in living cells.A hardwired HIV latency program.An evolutionary role for HIV latency in enhancing viral transmission.Proteomic analysis of HIV-T cell interaction: an updateHIV-1 transcription and latency: an update.Oral complications of HIV disease.HIV interactions with monocytes and dendritic cells: viral latency and reservoirs.The utilization of humanized mouse models for the study of human retroviral infections.Regulation of HIV-1 transcription at 3% versus 21% oxygen concentrationMolecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.Cellular and molecular mechanisms involved in the establishment of HIV-1 latency.HIV eradication: combinatorial approaches to activate latent viruses.Progress and challenges in the use of latent HIV-1 reactivating agentsLatency profiles of full length HIV-1 molecular clone variants with a subtype specific promoter.Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator ComplexIntracellular transactivation of HIV can account for the decelerating decay of virus load during drug therapy.A doxycycline-dependent human immunodeficiency virus type 1 replicates in vivo without inducing CD4+ T-cell depletion.The 2008 Retrovirology Prize: Ben Berkhout and his RNA world.EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment.
P2860
Q24654458-2037E8A8-53FA-468D-A77A-934560E123E6Q26995220-DC08B8F5-E6C4-4FC1-B545-B0B3013C8673Q28475636-04D67030-C33C-4E98-9375-7D85A8F134D6Q28596842-CB7421C4-D5BC-4802-A6AC-3F17C39BB16BQ30488246-BA7563F8-2F9B-4AB2-BCCD-B0A28E4D4937Q33347964-02279D5C-938C-45CC-BF3B-81EDD0A3DDEAQ33768729-D7462283-EE92-438C-A804-57F0437E482CQ33877492-16B5C447-D5F1-4777-8FBB-18857991BB9AQ34243934-96B1F09A-93FE-451E-A091-002EF97D2DC2Q34649701-3B5C2DB3-9765-4700-BB30-B0CFE1A22972Q35121356-4C34E0DB-A051-48CD-B96A-29CE0F125441Q35400385-8CC6B08B-5A2F-4A56-BD96-0A68F43B7CB8Q35807225-1DFB2023-4E26-4BBB-8625-10B090D84D1EQ36075318-E4944E7D-AE6E-4EB4-B371-420B818024CBQ36976156-2BC91E81-DAB7-4AC7-A11A-115526FFBAB5Q37222240-B49D0BF1-D7B6-4B2A-9DF6-A2DF841485FCQ37229398-F94B98D2-568C-4656-BBA6-0F45C8E2E4ACQ37346027-3A541F77-3AE9-4F3C-94A2-6A16F6357C99Q37423506-50F379E5-391C-4809-85D0-2A169E7B4EE9Q37644561-627590BF-5AC4-48D5-8875-744A722EA3A4Q38078562-7A7D8C75-3C6E-4960-8C83-47A8373B872CQ38271132-628E0DB2-6D9A-4766-9397-CEC72D5D37C3Q38509230-1C083B80-81EC-4D4A-A89A-710551C9C9B5Q38591360-EF4676DF-B189-4399-97E6-599513928705Q38818673-785113CC-FA3F-4D0C-8479-B9CBF8BD4FC2Q39521847-51C5AEF0-EB16-4804-A9DA-C955FAE8EBFEQ42142952-0581B08F-63EE-468D-AD5B-16576483B69FQ42636277-ACF3BC85-AFE9-418D-B4D4-6843668A4BC6Q55255033-584F2E21-0CB0-4C7C-A233-81B149A820F0
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
HIV-1 latency in actively dividing human T cell lines.
@en
type
label
HIV-1 latency in actively dividing human T cell lines.
@en
prefLabel
HIV-1 latency in actively dividing human T cell lines.
@en
P2093
P2860
P356
P1433
P1476
HIV-1 latency in actively dividing human T cell lines.
@en
P2093
Ben Berkhout
Ellen M Westerhout
Marja L van Gerven
Rienk E Jeeninga
P2860
P2888
P356
10.1186/1742-4690-5-37
P577
2008-04-25T00:00:00Z
P5875
P6179
1051160490